Mixed-model analysis of incomplete longitudinal data from a high-dose trial of tacrine (cognex^®) in alzheimer's patients

Abstract

Mixed-model techniques are applied to incomplete longitudinal data from a double-blind, placebo-controlled, parallel-group, high-dose study of tacrine in patients with Alzheimer's disease. The study consisted of a 30-week double-blind treatment period. Patients were randomized to one of four treatment groups. Dosing was initiated at 40 mg/day and increased in increments of 40 mg/day every 6 weeks until the target dose was achieved. If the study medication was not well tolerated or there were significant elevations in alanine aminotransferase, patients were withdrawn from the study. The use of SAS procedure PROC MIXED for the analysis of incomplete longitudinal data is discussed. This approach is used to evaluate disease progression over time and the effect of incremental dose increases of tacrine on changes on the Alzheimer's Disease Assessment Scale-Cognitive subscale.

Naloxone Challenge in Smokers

“…This model, which was determined to be a better fit for our repeated-measures study design with unequally spaced measurements, is also better at dealing with incomplete data sets. 20,21 Changes in craving for cigarettes were analyzed using a mixed model with dose of naloxone and time of measurement as within-subject factors. In cases of significant effects, multiple comparisons were conducted using least-square (adjusted) means.…”

3-Year Study of Donepezil Therapy in Alzheimer’s Disease: Effects of Early and Continuous Therapy

“…Although not ideal, mixed regression can go some way into providing a solution for such issues and provide greater statistical power than LOCF methods [10] . Although not a standard approach, mixed regression has been used to analyze longitudinal data from AD studies with tacrine [27] and sertraline [28] .…”